- November/December 2016MDLs 101: Primer on Multi-District Litigation
- Don’t Get Tagged – Avoiding Ethical Missteps with Social Media Investigations
- Stay Out of the Red this Black Friday
- The “Unstore”: The Future of Brick and Mortar Retail?
- Fall 2016Death by a Thousand Cuts: The Slow Erosion of the Right to Trial by Jury in Patent Cases
- The Future is Now
- November 11, 2016Spoilage Meets Spoliation: Duty to Preserve Perishable Goods in Litigation
- A Retail Robot Revolution is Not Far Off
- November 2016Who Bears the Burden?
- A Selfie’s Worth a Thousand Dollars
- Lessons from the Wells Fargo Scandal
- Fall 2016ANDA Litigation Settlements
- Fall 2016ANDA Approvals
- Fall 2016New ANDA Cases
- Genomics and FDA Regulation: A Work in Progress
- Fall 2016Generic Launches
- Eli Lilly & Co. v. Perrigo Co.
- Boehringer Ingelheim Pharma GMBH & Co. KG v. FDA
- Novartis AG v. Ezra Ventures, LLC
- Ferring Pharms., Inc. v. Burwell
- UCB, Inc. v. Accord Healthcare, Inc.
- Forest Labs. Holdings Ltd. v. Mylan Inc.
- Vanda Pharm. Inc. v. Roxane Labs., Inc.
- GlaxoSmithKline LLC v. Teva Pharms. USA, Inc.
- Sanofi v. Glenmark Pharms. Inc.
- Merck Sharp & Dohme B.V. v. Warner Chilcott Co., LLC
- Allergan Sales, LLC v. Sandoz, Inc.
- Torrent Pharmaceuticals Ltd. et al v. Daiichi Sankyo Co., Ltd., et al
- Horizon Pharma Ireland Ltd. v. Actavis Labs., UT, Inc.
- Tyco Healthcare Group LP v. Mutual Pharm. Co., Inc.
- The Medicines Co. v. Hospira, Inc.
- Fresenius Kabi USA, LLC v. Fera Pharms., LLC
- Bayer Pharma AG v. Watson Labs., Inc.
- Classen Immunotherapies, Inc. v. Elan Pharms., Inc.
- Fall 2016Antitrust Plays Whack-a-Mole as Exclusion of Competition by Drug Monopolists Pops Up Again: Gaming the “REMS”
- Brexit—The End of the Unitary Patent System as we Know it?
- October 14, 2016Insurers May Have A Duty To Prosecute Insured’s Counterclaims
- October 13, 2016Stare Decisis and Unpublished Opinions
- The Tech Industry’s Next Frontier?
- Radio Frequency Identification: Additional Considerations for Retailers
- There’s an App for that?
- September 21, 2016Whirlpool Effect: What if Petitioners Must Prove Proposed Amended Claims Are Unpatentable in IPRs?
- September 15, 2016What are the Limits of Sua Sponte Decision-Making?
- 20163D Printing of Medical Devices: CAD Designers as the Most Realistic Target for Strict, Product Liability
- How an obscure patent doctrine can cost you $1 billion a year. . .
- September 1, 2016Screening the Jury Pool
- August 11, 2016To Moot or not to Moot: What was the Question?
- August 2016Maximizing Your Chances for Oral Argument
- August 1, 2016The Halo Effect: More Jury Trials On Willfulness
- July 26, 2016Accelerator Focus On Retail
